Atorvastatin Reduces Plasma Inflammatory and Oxidant Biomarkers in Patients With Risk of Atherosclerotic Cardiovascular Disease
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiovascular Pharmacology and Therapeutics"
DOI: 10.1177/1074248417753677
Abstract: Background: Oxidative stress and inflammation are associated with endothelial injury and coronary artery disease. Inflammatory factors that promote oxidative damage include endothelin-1 (ET-1), myeloperoxidase (MPO), and C-reactive protein (CRP). Current guidelines recommend the use of… read more here.
Keywords: risk; risk ascvd; atorvastatin; disease ... See more keywords